Project/Area Number |
09670675
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Neurology
|
Research Institution | Kanazawa Medical University |
Principal Investigator |
OHARA Yoshiro Kanazawa Medical University, Department of Microbiology, Professor, 医学部, 教授 (50203914)
|
Co-Investigator(Kenkyū-buntansha) |
OBUCHI Masatsugu Kanazawa Medical University, Department of Microbiology, Assistant Professor, 医学部, 助手 (70257450)
村山 次哉 金沢医科大学, 医学部, 助教授 (60159184)
|
Project Period (FY) |
1997 – 1999
|
Project Status |
Completed (Fiscal Year 1999)
|
Budget Amount *help |
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 1999: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1998: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1997: ¥1,400,000 (Direct Cost: ¥1,400,000)
|
Keywords | Theiler's virus / CNS / lymphotoxin gene / vector / macrophages |
Research Abstract |
We reported that DA strain of Theiler's murine encephalomyelitis virus (TMEV) grows in macrophages where persists in the chronic stage if infection, therefore maintaining the genome. On the other hand, GDVII strain of TMEV does not grow there, and cannot maintain the genome (J Virol 71 : 729-733, 1997). Such a strain-specific, host cell-dependent virus growth was observed only in macrophages, but not in other types of cells (Microbiol Immunol, 43 : 885-892, 1999). Recombinant and mutant virus study also demonstrated that LィイD1*ィエD1 protein, which is out-of-frame with the polyprotein and translated from the alternative AUG within the L coding region, plays an important role for this phenomenon (J Virol 72 : 4950-4955, 1998). We finally inserted lymphotoxin (LT) gene into the L coding region of DA strain of TMEV and generated the recombinant virus. Western blotting and enzyme-linked immunosorbent assay demonstrated the expression of LT in BHK-21 cells infected with the recombinant virus. In addition, the expressed LT showed cytotoxicity against L-929 cells. Therefore, the present study provides a beginning of the use of TMEV as a vector for foreign gene delivery into the CNS.
|